organization · Reporting owner
Deerfield/RAB Ventures, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AdaptHealth Corp.
Report date December 20, 2019 · Filed December 26, 2019
Section 16 reporting ended · disclosed 2019-12-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-12-20 transaction · row 1
1 source rowRow 1 · 2019-12-20 · Other · Disposed 3,672,500 · Balance 0 F1: On December 20, 2019, Deerfield/RAB Ventures, LLC (the "Sponsor"), transferred 3,672,500 shares of Class A common stock of AdaptHealth Corp. ("Adapt") and 2,643,333 warrants to purchase shares of Adapt's Class A common stock to its members in connection with the dissolution of the Sponsor, for no consideration. |
| Private Placement WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2024-11-08 | Direct | 0 |
Reported balance
After 2019-12-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-12-20 · Other · Disposed 2,643,333 · Balance 0 F1: On December 20, 2019, Deerfield/RAB Ventures, LLC (the "Sponsor"), transferred 3,672,500 shares of Class A common stock of AdaptHealth Corp. ("Adapt") and 2,643,333 warrants to purchase shares of Adapt's Class A common stock to its members in connection with the dissolution of the Sponsor, for no consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 20, 2019, Deerfield/RAB Ventures, LLC (the "Sponsor"), transferred 3,672,500 shares of Class A common stock of AdaptHealth Corp. ("Adapt") and 2,643,333 warrants to purchase shares of Adapt's Class A common stock to its members in connection with the dissolution of the Sponsor, for no consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2019 Filed Dec 26, 2019 21:09 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherPrivate Placement Warrant · Derivative | 2,643,333 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-19-076127 · a4.xml · derivative · entry 2 Deerfield/RAB Ventures, LLC · CIK 0001731697 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,643,333 shares Expires 2024-11-08 F1 · kind: On December 20, 2019, Deerfield/RAB Ventures, LLC (the "Sponsor"), transferred 3,672,500 shares of Class A common stock of AdaptHealth Corp. ("Adapt") and 2,643,333 warrants to purchase shares of Adapt's Class A common stock to its members in connection with the dissolution of the Sponsor, for no consideration. F1 · price: On December 20, 2019, Deerfield/RAB Ventures, LLC (the "Sponsor"), transferred 3,672,500 shares of Class A common stock of AdaptHealth Corp. ("Adapt") and 2,643,333 warrants to purchase shares of Adapt's Class A common stock to its members in connection with the dissolution of the Sponsor, for no consideration. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:09 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherCommon Stock | 3,672,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-076127 · a4.xml · nonDerivative · entry 1 Deerfield/RAB Ventures, LLC · CIK 0001731697 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On December 20, 2019, Deerfield/RAB Ventures, LLC (the "Sponsor"), transferred 3,672,500 shares of Class A common stock of AdaptHealth Corp. ("Adapt") and 2,643,333 warrants to purchase shares of Adapt's Class A common stock to its members in connection with the dissolution of the Sponsor, for no consideration. F1 · price: On December 20, 2019, Deerfield/RAB Ventures, LLC (the "Sponsor"), transferred 3,672,500 shares of Class A common stock of AdaptHealth Corp. ("Adapt") and 2,643,333 warrants to purchase shares of Adapt's Class A common stock to its members in connection with the dissolution of the Sponsor, for no consideration. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 21:16 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherPrivate Placement Warrant · Derivative | 1,690,000 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-19-063327 · a4.xml · derivative · entry 2 Deerfield/RAB Ventures, LLC · CIK 0001731697 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,643,333 Underlying: Common Stock · 1,690,000 shares Expires 2024-11-08 F1 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F1 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 21:16 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherCommon Stock | 2,373,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-063327 · a4.xml · nonDerivative · entry 1 Deerfield/RAB Ventures, LLC · CIK 0001731697 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,672,500 F1 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F1 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 20:56 UTC | AdaptHealth Corp. DFBH · Entity 5183 | OtherCommon Stock | 921,848 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-022200 · a4.xml · nonDerivative · entry 1 Deerfield/RAB Ventures, LLC · CIK 0001731697 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,045,652 F1 · kind: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376). F1 · price: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376). F2 · balance_after: The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:31 UTC | AdaptHealth Corp. DFBH · Entity 5183 | PurchasePrivate Placement Warrant · Derivative | 4,333,333 | $1.50 Strike: $11.50 | $6,499,999.50 |
DisclosureSEC source: 0001104659-18-011754 · a4.xml · derivative · entry 1 Deerfield/RAB Ventures, LLC · CIK 0001731697 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,333,333 Underlying: Common Stock · 4,333,333 shares Expires not disclosed F1 · derivative.exercise_date: The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination or February 21, 2019. F2 · derivative.expiration_date: The warrants expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation. F3 · ownership.direct: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.